Similar Items: Repurposing quinoline-based (metallo) drug leads for the treatment of Leishmania major-induced cutaneous leishmaniasis
- Seroprevalence of canine leishmaniasis in Kwara, Oyo and Ogun states of Nigeria
- Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
- Efficacy and safety of novel and repurposed drugs for the treatment of drug-resistant tuberculosis
- Development of new metallo-drugs for haemozoin inhibition
- In silico synthesis of analogous lead libraries for drug design by molecular enumeration
- Investigating the role of B and T lymphocytes in the course of murine Leishmania Major infection
Author: Hurdayal, Ramona
- Repurposing quinoline-based (metallo) drug leads for the treatment of Leishmania major-induced cutaneous leishmaniasis
- Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection
- Nterleukin-4 responsive dendritic, macrophage/neutrophil cells are dispensable for host resistance against Leishmania Mexicana infection in mice
- Characterization of interleukin-4 induced gene-1 (IL-4I1) as a host immunoregulator to cutaneous leishmaniasis in cell based models
- Cysteinyl leukotriene receptor 1 as a host determinant for susceptibility to cutaneous leishmaniasis in a mouse model
- Investigating the role of IL-4Rα mediated signalling on Foxp3⁺ T regulatory cells during cutaneous leishmaniasis